Drug Shortage Resolved
Drug Shortage Resolved
Oxford Pharmaceutical's (Totowa, NJ) antidepressant drug “Marplan” (isocarboxazid, 10-mg dosage) has been removed from the US Food and Drug Administration’s list of drug shortages. Oxford resumed normal distribution of Marplan on May 27.
Marplan is a second-line treatment for depression offered as an option for patients who are unresponsive to other antidepressants such as selective serotonin reuptake inhibitors or traditional antidepressants such as amitriptyline.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
